Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bronchiolitis Obliterans Syndrome × Busulfan × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 54 Leukemia 48 Myelodysplastic Syndromes 46 Lymphoma 42 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Lymphoma, Non-Hodgkin 39 Hodgkin Disease 34 Multiple Myeloma 32 Leukemia, Lymphocytic, Chronic, B-Cell 29 Lymphoma, Mantle-Cell 23 Lymphoma, Large B-Cell, Diffuse 23 Lymphoma, Follicular 23 Neoplasms, Plasma Cell 21 Congenital Abnormalities 21 Lymphoma, B-Cell, Marginal Zone 20 Leukemia, Myelomonocytic, Chronic 20 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Burkitt Lymphoma 20 Lymphoma, Large-Cell, Immunoblastic 19 Leukemia, Myeloid, Accelerated Phase 19 Blast Crisis 19 Myeloproliferative Disorders 18 Leukemia, Myeloid, Chronic-Phase 18 Primary Myelofibrosis 16 Hematologic Neoplasms 14 Graft vs Host Disease 13 Lymphoma, T-Cell, Cutaneous 12 Dendritic Cell Sarcoma, Interdigitating 12 Myelodysplastic-Myeloproliferative Diseases 11 Anemia, Refractory, with Excess of Blasts 11

Interventions

tofacitinib 7 Rituximab 3 obinutuzumab 2 nilotinib 2 ibrutinib 2 bosutinib 2 Imatinib Mesylate 2 ruxolitinib 1 ofatumumab 1 fludarabine 1 canakinumab 1 belumosudil 1 baricitinib 1 axatilimab 1 Sofosbuvir 1 Ribavirin 1 Lenalidomide 1 KW-2478 1 KD025 1 Interleukin-15 1 Hsp90 inhibitor KU757 1 Etanercept 1 Dasatinib 1 Cyclophosphamide 1 Bortezomib 1 BMS-833923 1 B3(Fv)-PE38KDEL recombinant immunotoxin 1 Alemtuzumab 1 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡